April 19 (Reuters) - Adocia SA ADOC.PA :
* FY NET LOSS -22.8 MILLION EUR VERSUS -23.3 MILLION EUR
LOSS YEAR
AGO
* A CASH POSITION OF 15.2 MILLION EUROS ON DECEMBER 31,
2021,
STRENGTHENED TO 28 MILLION EUROS ON MARCH 28, 2022
* FY REVENUE OF EUR 1.4 MILLION IN 2021 (COMPARED TO EUR 0.8
MILLION IN 2020)
* FY OPERATING LOSS EUR 19.4 MILLION VERSUS LOSS OF EUR 21.1
MILLION YEAR AGO
* PROMISING PERSPECTIVES FOR 2022:- START OF BC LISPRO PHASE
3 IN
CHINA- COMPLETION OF CLINICAL STUDIES TO SUPPORT BC COMBO'S
PHASE 3 DOSSIER IN CHINA
* PROMISING PERSPECTIVES FOR 2022: PUBLICATION OF M1PRAM
(PHASE 2)
AND BC LISPRAM (PHASE 1) CLINICAL STUDIES RESULTS
* PROMISING PERSPECTIVES FOR 2022: PHASE 1 STUDIES
PREPARATION ON
OUR NEW PROJECTS
Source text for Eikon: urn:newsml:reuters.com:*:nBw3rYC1pa
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))